Patent details

EP3716952 Title: DOSAGE FORMS COMPRISING A PLASMA KALLIKREIN INHIBITOR

  • Data
  • Documents

Basic Information

Publication number:
EP3716952
PCT Application Number:
GB2018053443
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP188152938
PCT Publication Number:
WO2019106361
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGE FORMS COMPRISING A PLASMA KALLIKREIN INHIBITOR
French Title of Invention:
FORMES PHARMACEUTIQUES COMPRENANT UN INHIBITEUR DE LA KALLICRÉINE PLASMATIQUE
German Title of Invention:
DARREICHUNGSFORMEN MIT EINEM PLASMAKALLIKREININHIBITOR
SPC Number:

Dates

Filing date:
28/11/2018
Grant date:
05/01/2022
EP Publication Date:
07/10/2020
PCT Publication Date:
06/06/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/01/2022
EP B1 Publication Date:
05/01/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/11/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/12/2021
 
 

Name:
Kalvista Pharmaceuticals Limited
Address:
Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/02/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ROE, Michael Bryan
Address:
United Kingdom (GB)

2

Name:
COOK, Gary Paul
Address:
United States (US)

3

Name:
TODD, Richard Simon
Address:
United Kingdom (GB)

4

Name:
WARD, Robert Neil
Address:
United Kingdom (GB)

5

Name:
FARRAR, Jamie Joseph
Address:
United Kingdom (GB)

6

Name:
COLLETT, John Herman
Address:
United Kingdom (GB)

7

Name:
FRODSHAM, Michael John
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201762592242 P
Priority Date:
29/11/2017
Priority Country:
United States (US)

2

Priority Number:
201721515
Priority Date:
21/12/2017
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 9/20; A61K 9/28; A61K 9/48; A61K 9/16; A61K 31/00; A61K 31/444;

Publication

European Patent Bulletin

Issue number:
202201
Publication date:
05/01/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM